Literature DB >> 19596216

Perivascular epithelioid cell neoplasms: a systematic review of prognostic factors.

Nazila Zekry1, Mark A Rettenmaier, Lisa N Abaid, Cameron R John, John P Micha, John V Brown, Bram H Goldstein.   

Abstract

Perivascular epithelioid cell tumors (PEComas) are rare, soft tissue tumors characterized by epithelioid cells with clear or eosinophilic cytoplasm and a perivascular disbursement. We compiled the treatment and follow-up results from an extensive collection of reported gynecologic PEComa cases and statistically analyzed their respective therapy modalities and corresponding patient outcomes. In the group of patients with PEComa who received surgical management alone, there was a tendency for them to exhibit a lower disease recurrence rate. Conversely, patients with PEComa who initially received surgery and chemotherapy or radiation therapy were associated with a higher disease recurrence rate (P =.024). Metastatic involvement was related to higher patient mortality rates (P =.0001), although this finding was unrelated to treatment type. Surgical management alone may suffice for nonaggressive lesions, but chemotherapy and radiotherapy appear necessary for patients who present with high-risk histologic condition or metastatic disease. Because PEComas exhibit varying biologic behavior and an ill-defined presentation, the treatment for these lesions necessitates further evaluation.

Entities:  

Mesh:

Year:  2009        PMID: 19596216     DOI: 10.1016/j.jmig.2009.04.017

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  9 in total

1.  Perivascular Epithelioid Cell Tumour of the Uterus: a Case Report.

Authors:  G Nath Aswathy; P Rema; S Suchetha; J Sivaranjith; Dinesh Dhanya
Journal:  Indian J Surg Oncol       Date:  2020-06-20

2.  Primary perivascular epithelioid cell tumour (PEComa) of the liver.

Authors:  Tan To Cheung; Nigel Trendell-Smith; Ronnie T P Poon
Journal:  BMJ Case Rep       Date:  2013-07-10

3.  Hepatic multiple perivascular epithelioid cell neoplasm: A case report and literature review.

Authors:  Yin Zhi Lan; Xiao En Hua
Journal:  Mol Clin Oncol       Date:  2016-01-22

4.  Malignant perivascular epithelioid cell tumor of the uterus.

Authors:  Jonathan S Bleeker; J Fernando Quevedo; Andrew L Folpe
Journal:  Rare Tumors       Date:  2012-03-12

5.  "Malignant" perivascular epithelioid cell neoplasm: risk stratification and treatment strategies.

Authors:  Jonathan S Bleeker; J Fernando Quevedo; Andrew L Folpe
Journal:  Sarcoma       Date:  2012-04-26

6.  Uterine perivascular epithelioid tumors (PEComas) with lung metastasis showed good responses to mTOR and VEGFR inhibitors: A case report.

Authors:  Chengxu Sui; Jie Wu; Dan Mei; Evenki Pan; Peng Yang; Tingting Wu; Yutong Ma; Qiuxiang Ou; Lei Song
Journal:  Front Oncol       Date:  2022-07-28       Impact factor: 5.738

7.  Successful treatment with the mTOR inhibitor everolimus in a patient with perivascular epithelioid cell tumor.

Authors:  Constantine Gennatas; Vasiliki Michalaki; Paraskevi Vasilatou Kairi; Agathi Kondi-Paphiti; Dionysios Voros
Journal:  World J Surg Oncol       Date:  2012-09-03       Impact factor: 2.754

8.  Perivascular epithelioid cell tumor of the uterus: Report of two cases and mini-review of the literature.

Authors:  Charalampos Theofanakis; Nikolaos Thomakos; Maria Sotiropoulou; Alexandros Rodolakis
Journal:  Int J Surg Case Rep       Date:  2016-09-24

9.  Feasibility and Long-Term Efficacy of PEComa Treatment-20 Years of Experience.

Authors:  Aleksandra Sobiborowicz; Tomasz Świtaj; Paweł Teterycz; Mateusz J Spałek; Anna Szumera-Ciećkiewicz; Michał Wągrodzki; Marcin Zdzienicki; Anna M Czarnecka; Piotr Rutkowski
Journal:  J Clin Med       Date:  2021-05-19       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.